In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

David Carlson

Latest From David Carlson

Are State Price Transparency Requirements A Blind Spot In Biopharma Pricing Strategies?

As more and more states enact drug pricing transparency reporting requirements, biopharma companies should effectively manage business impacts and address reputational and competitive vulnerabilities associated with increased transparency to avoid hefty penalties for noncompliance. This changing landscape means manufacturers should not only build stronger compliance and reporting operations supported by automation, but also enhance analytics to incorporate the impacts of state regulations on pricing strategy.

Market Access Pricing Strategies
See All
UsernamePublicRestriction

Register